2218.7000 52.10 (2.40%)
NSE Oct 26, 2026 13:53 PM
Volume: 791.9K
 

2218.70
2.40%
Rudra Shares and Stock Brokers Ltd
GPL is primarily focused on building a global Generics, Specialty and OTC business in the therapy areas of Dermatology, Respiratory and Oncology. It also has strong regional/country specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives. Has 5 US FDA approved formulation...
Number of FII/FPI investors increased from 473 to 502 in Sep 2026 qtr.
More from Glenmark Pharmaceuticals Ltd.
Recommended